Suppr超能文献

在来自HIV阳性患者的唑类耐药白色念珠菌中检测人P-糖蛋白样分子。

Detection of human P-glycoprotein-like molecule in azole-resistant Candida albicans from HIV+ patients.

作者信息

Stringaro Annarita, Molinari Agnese, Calcabrini Annarica, Arancia Giuseppe, Ceddia Pier Giuseppe, Cianfriglia Maurizio, Poloni Francesca, Mondello Francesca, Angiolella Letizia, De Bernardis Flavia, Cassone Antonio

机构信息

Laboratorio di Ultrastrutture, Istituto Superiore di Sanità, Rome, Italy.

出版信息

Microb Drug Resist. 2002 Fall;8(3):235-44. doi: 10.1089/107662902760326968.

Abstract

Azole resistance in Candida albicans may be due to several mechanisms. It has been demonstrated that C. albicans possesses sequences with a high degree of homology with the human MDR-1 gene coding for P-glycoprotein (P-gp), belonging to the ATP-binding cassette transporter (ABC) superfamily and responsible for the multidrug resistance (MDR) in tumor cells. On this basis, the expression and intracellular localization of human P-gp-like molecule in C. albicans strains showing different sensitivity to fluconazole were investigated by flow cytometry and immunoelectron microscopy. Post-embedding immunolabeling revealed that monoclonal antibody (mAb) MM4.17, which recognizes an external epitope of human P-gp, reacted with both fluconazole-sensitive (3153 and CO 23-1) and fluconazole-resistant (AIDS 68 and CO 23-2, isolated from AIDS patient and in vitro drug-selected, respectively) strains of C. albicans. However, the resistant strains displayed a number of MM4.17-reactive epitopes much higher than the drug-sensitive ones. The C. krusei ATCC 6458 strain, whose resistance is not mediated by the presence of ABC transporters, was not reactive at all with mAb MM4.17. The specificity of the immunolabeling was confirmed by a competitive inhibition assay performed by using phage clone particles capable of mimicking the MM4.17-reactive epitope. The flow cytometric analysis confirmed a higher level of intracytoplasmic P-gp expression in azole-resistant strains of C. albicans. Both cyclosporin A and verapamil, which are well-known MDR inhibitors, strongly reduced the MICs for fluconazole and itraconazole of the tested azole-resistant AIDS 68 strain, while they did not influence the MICs of either the sensitive 3153 strain of C. albicans or the ATCC 6458 strain of C. krusei. Overall, our data suggest the existence of a P-gp-like drug efflux pump in C. albicans that may participate in the mechanisms of azole-resistance of this fungus.

摘要

白色念珠菌对唑类药物的耐药性可能由多种机制引起。已经证明,白色念珠菌拥有与编码P-糖蛋白(P-gp)的人类MDR-1基因具有高度同源性的序列,P-糖蛋白属于ATP结合盒转运蛋白(ABC)超家族,负责肿瘤细胞中的多药耐药性(MDR)。在此基础上,通过流式细胞术和免疫电子显微镜研究了对氟康唑敏感性不同的白色念珠菌菌株中人类P-gp样分子的表达和细胞内定位。包埋后免疫标记显示,识别人类P-gp外部表位的单克隆抗体(mAb)MM4.17与氟康唑敏感菌株(3153和CO 23-1)以及氟康唑耐药菌株(分别从艾滋病患者中分离和体外药物筛选得到的AIDS 68和CO 23-2)均发生反应。然而,耐药菌株显示出的MM4.17反应性表位数量远高于药物敏感菌株。克柔念珠菌ATCC 6458菌株的耐药性不是由ABC转运蛋白的存在介导的,与mAb MM4.17完全没有反应。通过使用能够模拟MM4.17反应性表位的噬菌体克隆颗粒进行的竞争抑制试验证实了免疫标记的特异性。流式细胞术分析证实,白色念珠菌唑类耐药菌株中细胞质内P-gp的表达水平更高。环孢素A和维拉帕米都是著名的MDR抑制剂,它们强烈降低了受试唑类耐药AIDS 68菌株对氟康唑和伊曲康唑的最低抑菌浓度(MIC),而它们对白色念珠菌敏感3153菌株或克柔念珠菌ATCC 6458菌株的MIC均无影响。总体而言,我们的数据表明白色念珠菌中存在一种P-gp样药物外排泵,它可能参与了该真菌对唑类药物的耐药机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验